Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Soria

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The European Respiratory Journal|October 19, 2011
Unmasking tuberculosis in the era of antiretroviral treatmentGiuseppe Lapadula, Alessandro Soria, Alessandra Bandera, et al.
Sexually Transmitted Infections|October 14, 2024
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence studyBianca Monti, Roberto Rossotti, Fabiana D'Aloia, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2010
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trialAlessandro Soria, Anna Danise, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
Clinical & Developmental Immunology|April 11, 2012
Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activationMonica Airoldi, Alessandra Bandera, Daria Trabattoni, et al.
Plos One|November 11, 2011
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapyAlessandro Soria, Franca Rosa Guerini, Alessandra Bandera, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2026
HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIVGiuseppe Lapadula, Alessandro Soria, Laura Antolini, et al.
Sexually Transmitted Infections|March 30, 2022
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workersGiuseppe Lapadula, Alessandro Soria, Massimo Modesti, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2018
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimenNicola Squillace, Daria Trabattoni, Antonio Muscatello, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The European Respiratory Journal|October 19, 2011
Unmasking tuberculosis in the era of antiretroviral treatmentGiuseppe Lapadula, Alessandro Soria, Alessandra Bandera, et al.
Sexually Transmitted Infections|October 14, 2024
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence studyBianca Monti, Roberto Rossotti, Fabiana D'Aloia, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2010
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trialAlessandro Soria, Anna Danise, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
Clinical & Developmental Immunology|April 11, 2012
Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activationMonica Airoldi, Alessandra Bandera, Daria Trabattoni, et al.
Plos One|November 11, 2011
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapyAlessandro Soria, Franca Rosa Guerini, Alessandra Bandera, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2026
HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIVGiuseppe Lapadula, Alessandro Soria, Laura Antolini, et al.
Sexually Transmitted Infections|March 30, 2022
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workersGiuseppe Lapadula, Alessandro Soria, Massimo Modesti, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2018
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimenNicola Squillace, Daria Trabattoni, Antonio Muscatello, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Pageof 6